Noile-Immune Biotech News

Noile-Immune Biotech: Notice of convocation of the 2025 Annual General Meeting of Shareholders and Shareholders' Meeting Materials

Mar 4 18:00 ET

Noile-Immune Biotech: Notice Concerning the Introduction of a Stock Remuneration System with Transfer Restrictions

Feb 21 04:00 ET

Noile-Immune Biotech: Summary of financial results for the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)

Feb 14 03:00 ET

Noile-Immune Biotech: Notice of conclusion of an option agreement with the University of Tokyo regarding polymer compounds for nucleic acid delivery

Feb 4 03:00 ET

Noile-Immune Biotech: Notice regarding the selection of loan stocks for our shares

Dec 20, 2024 03:00 ET

Noile-Immune Biotech: (Correction) Partial Corrections to the “Notice Concerning the Recording of Non-operating Income”

Nov 18, 2024 04:00 ET

Noile-Immune Biotech: Notice Concerning the Recording of Non-Operating Profit

Nov 14, 2024 01:30 ET

Noile-Immune Biotech: Notice regarding publication of earnings forecasts

Nov 14, 2024 01:30 ET

Noile-Immune Biotech: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)

Nov 14, 2024 01:30 ET

Noile-Immune Biotech: Correction Confirmation Form

Oct 14, 2024 23:07 ET

Noile-Immune Biotech: Revised Semi-Annual Report - Term 10 (2024/01/01 to 2024/12/31)

Oct 14, 2024 23:06 ET

Noile-Immune Biotech: (Correction) Partial Corrections to the “Notice Concerning Prioritization of Our Drug Discovery Pipeline and Associated Changes in the Use of Funds Raised at the Time of Listing”

Oct 11, 2024 04:00 ET

Noile-Immune Biotech: Notice regarding a business alliance with Takara Bio Co., Ltd. for the development of NIB103

Sep 25, 2024 02:00 ET

Noile-Immune Biotech: Semi-Annual Report - Term 10 (2024/01/01 - 2024/12/31)

Aug 12, 2024 23:02 ET

Noile-Immune Biotech: Confirmatory letter.

Aug 12, 2024 23:00 ET

Noile-Immune Biotech: 2nd quarter (interim) financial report for the fiscal year ending December 2024 [Japan Standard] (non-consolidated)

Aug 9, 2024 04:45 ET

Noile-Immune Biotech: Change Report

Jul 31, 2024 03:05 ET

Noile-Immune Biotech: Change report.

Jul 26, 2024 03:05 ET

Noile-Immune Biotech: Announcements of individual stocks regarding the re-prioritization of our in-house drug development pipeline and changes in the use of funds raised at the time of listing.

Jun 28, 2024 04:00 ET

Noile-Immune Biotech: Regarding the return of NIB102 and NIB103 to Takeda Pharmaceutical.

Jun 23, 2024 20:12 ET